EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Population-based survival analysis of primary spinal chordoma in the US from 2000 to 2020

Kevin E Agner, Michael C Larkins

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-024-04807-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Kevin E Agner und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University College of Medicine, 370 W. 9th Avenue, Columbus, OH, 43210, USA. Hauptthemen laut MEDLINE: Chordoma, Spinal Neoplasms, SEER Program. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Chordomas are rare malignant tumors that occur primarily in the axial skeleton. We seek to analyze trends affecting five-year overall survival (5y OS) among patients with primary spinal chordomas (PSC) of the vertebrae and sacrum/pelvis.

Methods

The Surveillance, Epidemiology, and End Results (SEER) Program was used to identify patients with PSC (ICD-O-3 histology codes 9370/3, 9371/3, and 9372/3) of the spine or sacrum/pelvis. Multivariate and univariate survival analyses were conducted to assess demographic, disease, or treatment characteristic trends.

Results

Eight-hundred-ninety-six patients diagnosed with PSC were identified. Patients 0–54 years at diagnosis had improved 5y OS compared to those either 55–69 years (HR = 1.78; p = 0.046) or those between 70 and 85 + years (HR = 3.92; p < 0.001). Histology impacted 5y OS: Cox regression demonstrated variance among the three histologies assessed ( p < 0.001), while univariate analysis demonstrated patients with dedifferentiated chordoma (1.0% of cohort; 33.3% [1.9,64.7]) and chondroid chordoma (2.0% of cohort; 52.5% [26.1,78.9]) had decreased 5y OS compared to those with general chordoma (72.2% [68.8,75.6]; p < 0.001). Nonmarried patients had decreased 5y OS on univariate analysis (65.2% [59.4,71.0] versus 76.2% [72.0,80.4]), with widowed patients being the primary driver of this on subanalysis. Treatment with gross total resection was associated with increased 5y OS (HR = 0.22, p < 0.001), as was treatment with radiotherapy (HR = 0.69, p = 0.030).

Conclusion

Patient age and marital status were significant demographic factors associated with changes in 5y OS among those with PSC. PSC histology is a potentially important prognostic factor in the management of disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChordomaSpinal NeoplasmsSEER ProgramHumansMaleMiddle AgedFemaleAgedAdultAdolescentYoung AdultChild, PreschoolChildAged, 80 and overUnited StatesInfantSurvival RateInfant, NewbornSurvival AnalysisPrognosisFollow-Up Studies

Stichwörter der Autor:innen

Histologic cancer analysisPopulation-level analysisSEER programSpinal chordomaSurgical oncology

Autor:innen und Institutionen

  • The Ohio State University College of Medicine, 370 W. 9th Avenue, Columbus, OH, 43210, USA.
  • East Carolina University Brody School of Medicine, 600 Moye Blvd, Greenville, NC, 27834, USA. larkinsm20@students.ecu.edu.
  • Department of Emergency Medicine, Boonshoft School of Medicine at Wright State University, 2555 University Blvd, Fairborn, OH, USA. larkinsm20@students.ecu.edu.

Zitieren

APA

Agner, K. E., & Larkins, M. C. (2024). Population-based survival analysis of primary spinal chordoma in the US from 2000 to 2020. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04807-y

Vancouver

Agner KE, Larkins MC. Population-based survival analysis of primary spinal chordoma in the US from 2000 to 2020. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04807-y

BibTeX
@article{Agner2024,
  author = {Agner, Kevin E and Larkins, Michael C},
  title = {Population-based survival analysis of primary spinal chordoma in the US from 2000 to 2020},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-024-04807-y}
}
Kostenlos starten →